Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Infantile Hemangioma
NCT01056341Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Jan 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of propranolol in infantile hemangioma (IH), sponsored by Pierre Fabre Laboratories. Started Jan 2010; status: completed.
02
Drugs
propranolol
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT01056341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01056341.